Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Vascular Surgery

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 108 articles: HTML format

Single Articles

February 2026
1. CAO JY, Egbe AC, Olsen N, Jain CC, et al
   Adults with Fontan circulation: prognostic value of exercise pulmonary vascular resistance index.
   Eur Heart J. 2026;47:854-864.
   PubMed     Abstract available
   
   
   
2. LEE SJ, Lee SJ, Hong SJ, Cho DK, et al
   Optical coherence tomography-guided stent optimization for complex coronary lesions: the OCCUPI trial.
   Eur Heart J. 2026;47:608-621.
   PubMed     Abstract available
   
   
   January 2026
3. SAVONITTO S, Alpert JS, Thiele H, Campo G, et al
   Non-ST-segment elevation acute coronary syndrome: understanding the full spectrum to guide management.
   Eur Heart J. 2026;47:423-437.
   PubMed     Abstract available
   
   
   November 2025
4. SERRUYS PW, Oshima A, Ferraz-Costa G, Garg S, et al
   Coronary revascularization: a long-term perspective.
   Eur Heart J. 2025 Nov 22:ehaf883. doi: 10.1093.
   PubMed     Abstract available
   
   
   October 2025
5. PADALINO MA, Constantine A, Bergonzoni E, Cao I, et al
   Early outcomes of children with univentricular circulation undergoing Fontan surgery: the EuroFontan registry.
   Eur Heart J. 2025 Oct 23:ehaf835. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. LOMBARDI M, Boivin-Proulx LA, Jeronimo A, Mejia-Renteria H, et al
   Angina after percutaneous coronary interventions.
   Eur Heart J. 2025 Oct 17:ehaf771. doi: 10.1093.
   PubMed     Abstract available
   
   
   
7. GARCIA-PAVIA P, Gonzalez-Lopez E, Anderson LJ, Cappelli F, et al
   Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association.
   Eur Heart J. 2025 Oct 7:ehaf710. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2025
8. MANGIACAPRA F, Paolucci L, De Bruyne B, Rioufol G, et al
   Fractional flow reserve vs angiography to guide percutaneous coronary intervention: an individual patient data meta-analysis.
   Eur Heart J. 2025 Aug 20:ehaf504. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. GUO ZN, Abuduxukuer R, Wang C, Qu Y, et al
   Remote ischaemic conditioning improves outcomes of ischaemic stroke treated by endovascular thrombectomy: the SERIC-EVT trial.
   Eur Heart J. 2025 Aug 12:ehaf570. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. CHEN J, Xu C, Qiu L, Li B, et al
    Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial.
    Eur Heart J. 2025 Aug 1:ehaf481. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2025
11. SCHLAGER O, De Carlo M, Mazzolai L, Bura-Riviere A, et al
    Antithrombotic treatment following revascularization for chronic limb-threatening ischaemia: a scientific statement of the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society of Cardiology Wo
    Eur Heart J. 2025;46:2742-2759.
    PubMed     Abstract available
    
    
    
12. FEZZI S, Scheller B, Cortese B, Alfonso F, et al
    Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium.
    Eur Heart J. 2025;46:2498-2519.
    PubMed     Abstract available
    
    
    
13. FAZEL R, Rao SV, Cohen DJ, Secemsky EA, et al
    Radial vs femoral access for percutaneous coronary intervention: temporal trends and outcomes in the USA.
    Eur Heart J. 2025 Jul 4:ehaf426. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
14. RYAN M, Petrie MC, Kontopantelis E, Dodd M, et al
    Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis.
    Eur Heart J. 2025;46:2052-2062.
    PubMed     Abstract available
    
    
    
15. MAHENDIRAN T, Bouisset F, Tonino P, Pijls NHJ, et al
    Titanium-nitride-oxide-coated vs. drug-eluting stents in acute coronary syndromes: an individual patient data meta-analysis.
    Eur Heart J. 2025;46:2092-2100.
    PubMed     Abstract available
    
    
    
16. ALI ZA, Shin D, Vijayvergiya R, Gawalkar AA, et al
    Optical coherence tomography- vs angiography-guided coronary stent implantation in calcified lesions: the ILUMIEN IV trial.
    Eur Heart J. 2025 Jun 5:ehaf331. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2025
17. KIM MC, Park SJ, Park DW, Ahn JM, et al
    Preventive percutaneous coronary intervention for non-flow-limiting vulnerable atherosclerotic coronary plaques in diabetes: the PREVENT trial.
    Eur Heart J. 2025 May 29:ehaf273. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. MONTANARO C, Arvanitaki A, Kerrigan W, Kadani Z, et al
    The Fontan Adult Brompton clinical score and mortality risk.
    Eur Heart J. 2025;46:1933-1945.
    PubMed     Abstract available
    
    
    
19. HANSSON EC, Omerovic E, Venetsanos D, Alfredsson J, et al
    Coronary artery bypass grafting with or without preoperative physiological stenosis assessment: a SWEDEHEART study.
    Eur Heart J. 2025 May 16:ehaf327. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. POUNCEY AL, Sweeting MJ, Bicknell C, Powell JT, et al
    Sex-specific differences in alive hospital discharge following infrarenal abdominal aortic aneurysm repair.
    Eur Heart J. 2025;46:1705-1716.
    PubMed     Abstract available
    
    
    
21. FEZZI S, Giacoppo D, Fahrni G, Latib A, et al
    Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study.
    Eur Heart J. 2025;46:1586-1599.
    PubMed     Abstract available
    
    
    
22. ZHANG Q, Li H, Zhuang T, Xu L, et al
    CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin beta4 and Cd9 pathway.
    Eur Heart J. 2025;46:1645-1658.
    PubMed     Abstract available
    
    
    April 2025
23. BAY B, Tanner R, Gao M, Oliva A, et al
    Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary interventiondagger.
    Eur Heart J. 2025 Apr 10:ehaf196. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2025
24. JIA P, Zhao G, Huang Y, Zou Z, et al
    Remote ischaemic pre-conditioning, kidney injury, and outcomes after coronary angiography and intervention: a randomized trial.
    Eur Heart J. 2025 Mar 11:ehaf135. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. CALAFIORE AM, Prapas S, Gaudino M
    Arterial conduits for coronary bypass grafting: the set-point concept.
    Eur Heart J. 2025;46:922-925.
    PubMed     Abstract available
    
    
    February 2025
26. THELIN S, Modrau IS, Duvernoy O, Dalen M, et al
    No-touch vein grafts in coronary artery bypass surgery: a registry-based randomized clinical trial.
    Eur Heart J. 2025 Feb 19:ehaf018. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2025
27. WILKINSON C, Bhatty A, Batra G, Aktaa S, et al
    Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
    Eur Heart J. 2025;46:190-214.
    PubMed     Abstract available
    
    
    December 2024
28. FERREIRA D, Hardy J, Meere W, Butel-Simoes L, et al
    Fasting vs. no fasting prior to catheterization laboratory procedures: the SCOFF trial.
    Eur Heart J. 2024;45:4990-4998.
    PubMed     Abstract available
    
    
    November 2024
29. OMEROVIC E, Ramunddal T, Petursson P, Angeras O, et al
    Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry.
    Eur Heart J. 2024 Nov 27:ehae700. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. WANG Y, Zeller M, Auffret V, Georgiopoulos G, et al
    Sex-specific prediction of cardiogenic shock after acute coronary syndromes: the SEX-SHOCK score.
    Eur Heart J. 2024;45:4564-4578.
    PubMed     Abstract available
    
    
    
31. LANDMESSER U, Ali ZA, Maehara A, Matsumura M, et al
    Optical coherence tomography predictors of clinical outcomes after stent implantation: the ILUMIEN IV trial.
    Eur Heart J. 2024;45:4630-4643.
    PubMed     Abstract available
    
    
    October 2024
32. BLOOM JE, Vogrin S, Reid CM, Ajani AE, et al
    Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survival.
    Eur Heart J. 2024 Oct 29:ehae672. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. KANG D, Choi KH, Kim H, Park H, et al
    Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study.
    Eur Heart J. 2024 Oct 21:ehae705. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. SANDNER S, Antoniades C, Caliskan E, Czerny M, et al
    Intra-operative and post-operative management of conduits for coronary artery bypass grafting: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Surgery and the European Association for Cardio-Thoraci
    Eur Heart J. 2024 Oct 16:ehae654. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2024
35. LIU W, Cui C, Wang B
    Six-vessel fenestrated physician-modi fi ed stent grafts for treating thoracic aortic dissecting aneurysm and giant abdominal aortic aneurysm.
    Eur Heart J. 2024;45:3765.
    PubMed    
    
    
    
36. LIUZZO G, Patrono C
    Weekly Journal Scan: a penULTIMATE frontier for optimal antiplatelet therapy after drug-eluting stenting in acute coronary syndromes?
    Eur Heart J. 2024;45:3108-3110.
    PubMed    
    
    
    
37. EITEL I, Saraei R, Jurczyk D, Fach A, et al
    Glycoprotein IIb/IIIa Inhibitors in Acute Myocardial Infarction and Angiographic Microvascular Obstruction: The REVERSE-FLOW Trial.
    Eur Heart J. 2024 Sep 1:ehae587. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. TANIWAKI M, Haner JD, Kakizaki R, Ohno Y, et al
    Long-term effect of biodegradable vs durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial.
    Eur Heart J. 2024 Sep 1:ehae589. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2024
39. WATANABE H, Natsuaki M, Morimoto T, Yamamoto K, et al
    Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention: 1-Year Follow-up of the STOPDAPT-3 Trial.
    Eur Heart J. 2024 Aug 31:ehae617. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. VALGIMIGLI M, Landi A
    Bleeding risk should guide antithrombotic treatment after percutaneous coronary intervention: a Copernican revolution.
    Eur Heart J. 2024 Aug 28:ehae542. doi: 10.1093.
    PubMed    
    
    
    
41. SCHELLER B, Zeller T
    Paclitaxel-coated balloons: the more you gain the more you get.
    Eur Heart J. 2024;45:2848-2850.
    PubMed    
    
    
    
42. KO YG, Lee SJ, Ahn CM, Lee SH, et al
    Intravascular ultrasound-guided drug-coated balloon angioplasty for femoropopliteal artery disease: a clinical trial.
    Eur Heart J. 2024;45:2839-2847.
    PubMed     Abstract available
    
    
    
43. RICHTER M, Venkiteswaran VK, de Vries JP, Misra S, et al
    APOLLO: advanced magnetic probes for minimally invasive endovascular interventions.
    Eur Heart J. 2024;45:2589-2591.
    PubMed    
    
    
    
44. PEDICINO D, Vergallo R
    Weekly Journal Scan: Drug-coated balloon for the treatment of in-stent restenosis - the AGENT IDE trial.
    Eur Heart J. 2024;45:2592-2593.
    PubMed    
    
    
    July 2024
45. BESOLA L, Colli A, De Caterina R
    Coronary bypass surgery for multivessel disease after percutaneous coronary intervention in acute coronary syndromes: why, for whom, how early?
    Eur Heart J. 2024 Jul 26:ehae413. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. KANG J, Yun J, Park KW, Park M, et al
    Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry.
    Eur Heart J. 2024 Jul 23:ehae462. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. CREA F
    Focus on acute myocardial infarction, sex-related differences in coronary bypass surgery, inflammation in heart failure, and infective endocarditis in prosthetic valves.
    Eur Heart J. 2024;45:2463-2467.
    PubMed    
    
    
    
48. AHMAD Y, Lansky AJ
    Periprocedural myocardial infarction: thresholds of (in)significance.
    Eur Heart J. 2024 Jul 19:ehae451. doi: 10.1093.
    PubMed    
    
    
    
49. DAFAALLA M, Costa F, Kontopantelis E, Araya M, et al
    Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
    Eur Heart J. 2024 Jul 17:ehae463. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. ANDREOTTI F, De Caterina R
    Anticoagulation for transient atrial fibrillation post-coronary bypass: high quality evidence needed.
    Eur Heart J. 2024 Jul 16:ehae402. doi: 10.1093.
    PubMed    
    
    
    
51. GE Y, Zhang H, Guo W
    First in man: blocking the false lumen backflow of aortic dissection after thoracic endovascular aortic repair by an off-the-shelf EndoSeal system.
    Eur Heart J. 2024;45:2461.
    PubMed    
    
    
    
52. GOROG DA
    Point-of-care tests of platelet reactivity and clot strength in risk assessment post-PCI: more insight into what really matters.
    Eur Heart J. 2024;45:2232-2234.
    PubMed    
    
    
    June 2024
53. SCHELDEMAN L, Sinnaeve P, Albers GW, Lemmens R, et al
    Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.
    Eur Heart J. 2024 Jun 28:ehae371. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. HOLFELD J, Nagele F, Polzl L, Engler C, et al
    Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
    Eur Heart J. 2024 Jun 20:ehae341. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. SCHLOTTER F, Huber K, Hassager C, Halvorsen S, et al
    Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular In
    Eur Heart J. 2024 Jun 18:ehae363. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. COUGHLAN JJ, Durand R, Byrne RA
    An initial invasive strategy in older patients with non-ST elevation acute coronary syndromes: it is never too late.
    Eur Heart J. 2024;45:2063-2065.
    PubMed    
    
    
    
57. KOTANIDIS CP, Mills GB, Bendz B, Berg ES, et al
    Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
    Eur Heart J. 2024;45:2052-2062.
    PubMed     Abstract available
    
    
    
58. BEERKENS FJ, Bhatt DL
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?
    Eur Heart J. 2024 Jun 7:ehae287. doi: 10.1093.
    PubMed    
    
    
    May 2024
59. REN J, Bowyer A, Tian DH, Royse C, et al
    Multiple arterial vs. single arterial coronary artery bypass grafting: sex-related differences in outcomes.
    Eur Heart J. 2024 May 31:ehae294. doi: 10.1093.
    PubMed     Abstract available
    
    
    
60. VAN DE KAR MRD, van Brakel TJ, Van't Veer M, van Steenbergen GJ, et al
    Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis.
    Eur Heart J. 2024 May 29:ehae267. doi: 10.1093.
    PubMed     Abstract available
    
    
    
61. KELHAM M, Vyas R, Ramaseshan R, Rathod K, et al
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management.
    Eur Heart J. 2024 May 28:ehae245. doi: 10.1093.
    PubMed     Abstract available
    
    
    
62. KWON O, Ahn JH, Koh JS, Park Y, et al
    Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
    Eur Heart J. 2024 May 28:ehae296. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. HARIK L, Gaudino M
    Coronary angiography and bypass surgery: born together and now going separate ways?
    Eur Heart J. 2024;45:1816-1818.
    PubMed    
    
    
    
64. SERRUYS PW, Kageyama S, Pompilio G, Andreini D, et al
    Coronary bypass surgery guided by computed tomography in a low-risk population.
    Eur Heart J. 2024;45:1804-1815.
    PubMed     Abstract available
    
    
    
65. ROFFI M, Meier B, Gallino A
    Fifty years of percutaneous transluminal angioplasty.
    Eur Heart J. 2024;45:1779-1780.
    PubMed    
    
    
    
66. GRIMALDI S, Migliorini P, Puxeddu I, Rossini R, et al
    Aspirin hypersensitivity: a practical guide for cardiologists.
    Eur Heart J. 2024;45:1716-1726.
    PubMed     Abstract available
    
    
    
67. LEE YJ, Shin S, Kwon SW, Suh Y, et al
    Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials.
    Eur Heart J. 2024 May 16:ehae249. doi: 10.1093.
    PubMed     Abstract available
    
    
    
68. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
    Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
    Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. ABOYANS V, De Carlo M
    Caring for patients with lower extremity artery disease: going beyond stents and bypass grafts.
    Eur Heart J. 2024;45:1644-1646.
    PubMed    
    
    
    
70. SHIBA M, Fukutome K, Higuchi Y
    Involvement of cholesterol crystals in the mechanism of aortogenic cerebral infarction: an angioscopic study.
    Eur Heart J. 2024;45:1686.
    PubMed    
    
    
    
71. VERGALLO R, Patrono C
    Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?
    Eur Heart J. 2024 May 4:ehae242. doi: 10.1093.
    PubMed    
    
    
    April 2024
72. KIM YY, Lluri G, Haeffele C, Daugherty T, et al
    Hepatocellular carcinoma in survivors after Fontan operation: a case-control study.
    Eur Heart J. 2024;45:1477-1480.
    PubMed    
    
    
    
73. VERGALLO R, Galiuto L
    Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial.
    Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093.
    PubMed    
    
    
    
74. CALLEGARI A, Bonnet D, Malekzadeh-Milani S
    Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion.
    Eur Heart J. 2024;45:1285.
    PubMed    
    
    
    
75. MATSUMURA H, Yashima F, Shimoji K
    Spontaneous kissing stent for total occlusion of the left main trunk complicated by Stanford Type A aortic dissection.
    Eur Heart J. 2024;45:1179.
    PubMed    
    
    
    March 2024
76. URSO S, Sadaba R, Dayan V
    Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
    Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
    PubMed    
    
    
    
77. VERGALLO R, Galiuto L
    Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?
    Eur Heart J. 2024 Mar 4:ehae119. doi: 10.1093.
    PubMed    
    
    
    February 2024
78. IKEDA R, Hiraoka A, Yoshitaka H
    Rupture of a 34-year-old Dacron graft after descending aortic replacement.
    Eur Heart J. 2024;45:636.
    PubMed    
    
    
    
79. XIE Y, Yang P, Hu J
    Off-the-shelf use of a novel unibody single-branched stent for open repair of a double chimney graft-induced retrograde type A aortic dissection.
    Eur Heart J. 2024;45:635.
    PubMed    
    
    
    
80. TARANTINI G, Putorti F, Nai Fovino L
    10-Year optical coherence tomography follow-up of 'full-plastic jacket' with bioresorbable vascular scaffolds.
    Eur Heart J. 2024;45:556.
    PubMed    
    
    
    
81. NISHIHIRA K, Asano Y, Shibata Y
    Efficacy of paclitaxel-coated balloon angioplasty combined with intensive lipid-lowering therapy for ST-segment elevation myocardial infarction: insights from near-infrared spectroscopy.
    Eur Heart J. 2024 Feb 15:ehae073. doi: 10.1093.
    PubMed    
    
    
    January 2024
82. SENIOR R, Khattar RS
    To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?
    Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093.
    PubMed    
    
    
    
83. NAKAJIMA A, Okutsu M, Nakamura S
    Optical coherence tomographic patterns of restenosis in patients treated with directional coronary atherectomy and drug-coated balloon therapy.
    Eur Heart J. 2024;45:315.
    PubMed    
    
    
    
84. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
    Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
    PubMed     Abstract available
    
    
    
85. CAPRANZANO P, Moliterno D, Capodanno D
    Aspirin-free antiplatelet strategies after percutaneous coronary interventions.
    Eur Heart J. 2024 Jan 18:ehad876. doi: 10.1093.
    PubMed     Abstract available
    
    
    
86. HAMILTON DE, Albright J, Seth M, Painter I, et al
    Merging machine learning and patient preference: a novel tool for risk prediction of percutaneous coronary interventions.
    Eur Heart J. 2024 Jan 17:ehad836. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. VERGALLO R, Galiuto L
    Shedding the optical coherence tomography light on the treatment of complex coronary bifurcation lesions.
    Eur Heart J. 2024;45:159-160.
    PubMed    
    
    
    
88. COSTA F, Montalto C, Valgimigli M
    One or 3 months dual antiplatelet therapy in high bleeding risk patients: splitting hair or aiming at the bullseye?
    Eur Heart J. 2024;45:71-72.
    PubMed    
    
    
    December 2023
89. BRIGNOLE M, Deharo JC
    Different techniques of venous access for CIEDs: advantages and disadvantages.
    Eur Heart J. 2023;44:4859-4861.
    PubMed    
    
    
    
90. ALFONSO F, Marschall A, Rivero F
    Revascularization for left main coronary artery disease.
    Eur Heart J. 2023;44:4893.
    PubMed    
    
    
    
91. PERSSON J, Ivert T, Omerovic E
    Observational studies are needed to complete the body of evidence for left main coronary artery disease revascularization strategies.
    Eur Heart J. 2023;44:4894.
    PubMed    
    
    
    
92. CHARLES P, Ditac G, Montoy M, Thenard T, et al
    Intra-pocket ultrasound-guided axillary vein puncture vs. cephalic vein cutdown for cardiac electronic device implantation: the ACCESS trial.
    Eur Heart J. 2023;44:4847-4858.
    PubMed     Abstract available
    
    
    
93. LI J, Li Q, Shu C
    Aortic intimal intussusception induced by stent-graft during endovascular repair of acute type B aortic dissection.
    Eur Heart J. 2023;44:4813.
    PubMed    
    
    
    November 2023
94. VERGALLO R, Volpe M
    Optical coherence tomography to guide percutaneous coronary intervention: is the glass half full or half empty?
    Eur Heart J. 2023 Nov 28:ehad792. doi: 10.1093.
    PubMed    
    
    
    
95. ZHAO Y, Chen Y
    What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention in high-bleeding risk: 1 month or 3 months?
    Eur Heart J. 2023 Nov 20:ehad728. doi: 10.1093.
    PubMed    
    
    
    
96. PEDICINO D, Liuzzo G
    Does MULTISTARS shed light on the timing of complete revascularization in ST-elevation myocardial infarction?
    Eur Heart J. 2023 Nov 18:ehad733. doi: 10.1093.
    PubMed    
    
    
    
97. GARCIA-MOLL X
    Where there is smoke there is risk: is there an irreversible threshold?
    Eur Heart J. 2023;44:4473-4475.
    PubMed    
    
    
    
98. DEMIDOVA MM, Holmqvist F, Erlinge D, Platonov PG, et al
    Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events.
    Eur Heart J. 2023 Nov 3:ehad740. doi: 10.1093.
    PubMed    
    
    
    
99. KIM H, Kang DY, Lee J, Choi Y, et al
    Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial.
    Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. CREA F
     Hot topics in interventional cardiology: left main disease, heavily calcified coronary stenoses, and physiology-guided percutaneous coronary interventions.
     Eur Heart J. 2023;44:4295-4299.
     PubMed    
     
     
     
101. BYRNE RA, Fremes S, Capodanno D, Czerny M, et al
     2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
     Eur Heart J. 2023;44:4310-4320.
     PubMed     Abstract available
     
     
     
102. JOHNSON NP, Ahn JM
     Left main PCI: beware the circumflex!
     Eur Heart J. 2023;44:4337-4339.
     PubMed    
     
     
     
103. BARBATO E, Gallinoro E, Abdel-Wahab M, Andreini D, et al
     Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group.
     Eur Heart J. 2023;44:4340-4356.
     PubMed     Abstract available
     
     
     
104. WANG HY, Zhang R, Dou K, Huang Y, et al
     Left main bifurcation stenting: impact of residual ischaemia on cardiovascular mortality.
     Eur Heart J. 2023;44:4324-4336.
     PubMed     Abstract available
     
     
     October 2023
105. ALI ZA, Shin D
     Intravascular imaging: a glass half empty or half full?
     Eur Heart J. 2023;44:3856-3858.
     PubMed    
     
     
     September 2023
106. KI YJ, Han K, Kim HS, Han JK, et al
     Smoking and cardiovascular outcomes after percutaneous coronary intervention: a Korean study.
     Eur Heart J. 2023 Sep 26:ehad616. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2023
107. FAZEL R, Yeh RW, Cohen DJ, Rao SV, et al
     Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA.
     Eur Heart J. 2023 Jul 19:ehad430. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2023
108. COLOMBO A, Leone PP
     Redefining the way to perform percutaneous coronary intervention: a view in search of evidence.
     Eur Heart J. 2023 Apr 11:ehad215. doi: 10.1093.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum